Targeting AMPK signaling in combating ovarian cancers: opportunities and challenges

Por Yung, Mingo M.H., Ngan, Hextan Y.S., Chan, David W.
Publicado no Acta Biochim Biophys Sin (Shanghai) (2016)

Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade

Por Yung, Mingo M. H., Ross, Fiona A., Hardie, D. Grahame, Leung, Thomas H. Y., Zhan, Jinbiao, Ngan, Hextan Y. S., Chan, David W.
Publicado no Integr Cancer Ther (2015)

AMPK Activators Suppress Cervical Cancer Cell Growth through Inhibition of DVL3 Mediated Wnt/β-Catenin Signaling Activity

Por Kwan, H. T., Chan, David W., Cai, Patty C. H., Mak, Celia S. L., Yung, Mingo M. H., Leung, Thomas H. Y., Wong, Oscar G. W., Cheung, Annie N. Y., Ngan, Hextan Y. S.
Publicado em 2013

Targeting GRB7/ERK/FOXM1 Signaling Pathway Impairs Aggressiveness of Ovarian Cancer Cells

Por Chan, David W., Hui, Winnie W. Y., Cai, Patty C. H., Liu, Michelle X., Yung, Mingo M. H., Mak, Celia S. L., Leung, Thomas H. Y., Chan, Karen K. L., Ngan, Hextan Y. S.
Publicado em 2012

MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis

Por Mak, Celia S. L., Yung, Mingo M. H., Hui, Lynn M. N., Leung, Leanne L., Liang, Rui, Chen, Kangmei, Liu, Stephanie S., Qin, Yiming, Leung, Thomas H. Y., Lee, Kai-Fai, Chan, Karen K. L., Ngan, Hextan Y. S., Chan, David W.
Publicado no Mol Cancer (2017)